Pear Therapeutics, Inc. Annual Costs and Expenses in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Pear Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2020 to 2022.
  • Pear Therapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2022 was $31.7M, a 10.8% decline year-over-year.
  • Pear Therapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2022 was $136M, a 23.8% increase year-over-year.
  • Pear Therapeutics, Inc. annual Costs and Expenses for 2022 was $136M, a 23.8% increase from 2021.
  • Pear Therapeutics, Inc. annual Costs and Expenses for 2021 was $110M, a 27.7% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $136M +$26.2M +23.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $110M +$23.9M +27.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $86M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.